Gateway Health Alliances inc

What Gateway Health Alliances inc does

Gateway Health Alliances (GHA) is a privately held ingredient supplier founded in 2005 and headquartered at 4769 Mangels Blvd, Fairfield, California. The company develops, patents, and sells five branded botanical extract ingredients — CQR-300 (Cissus quadrangularis), Dyglomera/DygloFit and Somnoril (both Dichrostachys glomerata), IGOB131 (Irvingia gabonensis), and LeptiCore (a multifunctional polysaccharide-and-phytonutrient complex) — to food, beverage, and dietary supplement manufacturers for applications including capsules, tablets, powdered mixes, and beverages. The portfolio is backed by more than 25 patents and over 10 randomized, double-blind, placebo-controlled human clinical studies covering 1,000+ participants, with documented mechanisms including GLP-1 elevation via DPP-4 inhibition, and modulation of leptin, adiponectin, and insulin.

GHA monetizes primarily through direct B2B sales of ingredients to manufacturers, with limited direct-to-consumer retail exposure (Somnoril and CQR-300 listed at $29.99 per 30-day supply). The company is led by President Shil Kothari and Product Development Manager Avi Kothari; only two named executives are documented and total headcount is reported as five. Recent activity centers on positioning GHA within the natural-GLP-1 conversation, including a January 2026 peer-reviewed publication in Medicina, an April 2026 SupplySide Supplement Journal webinar, and an October 2025 SupplySide Global panel. Compliance posture is established across the portfolio (GRAS for IGOB131, GRAS Self-Affirmed for Dyglomera, plus Kosher, Halal, Vegan, Vegetarian, Non-GMO, and Gluten-Free certifications for selected SKUs), supporting formulation into globally distributed finished products.

Name

Gateway Health Alliances inc

Legal name

Gateway Health Alliances, Inc.

Website

https://ghainc.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

Gateway Health Alliances is a privately held supplier of patented, clinically validated botanical extracts (CQR-300, Dyglomera, IGOB131, LeptiCore, Somnoril) serving food, beverage, and dietary supplement manufacturers with ingredients for weight management and metabolic health.

Ownership category

akta.pro rank

Headquarters

HQ city

Fairfield

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Ingredient Sales to Manufacturers: Gateway Health Alliances generates revenue by selling proprietary, clinically validated botanical ingredients to food, beverage, and dietary supplement manufacturers. The company offers ingredients for use in various product applications including capsules, tablets, powdered mixes, and beverages.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Gateway Health Alliances supplies proprietary, patented, clinically validated botanical extracts (CQR-300, Dyglomera, DygloFit, IGOB131, Somnoril, and LeptiCore) to food, beverage, and dietary supplement manufacturers worldwide for weight management, metabolic wellness, restorative sleep, and cardiovascular health formulations. The company also sells select ingredients (Somnoril and CQR-300) direct-to-consumer via its website as 30-day finished product offerings at $29.99.

Product overview

Gateway Health Alliances is a natural ingredient supplier offering a portfolio of clinically validated, patented botanical extracts for weight management, metabolic wellness, and restorative sleep. The core products include CQR-300 (Cissus quadrangularis), Dyglomera/DygloFit (Dichrostachys glomerata), Somnoril (also Dichrostachys glomerata for sleep applications), IGOB131 (Irvingia gabonensis), and LeptiCore (multifunctional ingredient complex). These branded ingredients work through distinct mechanisms including GLP-1 modulation, DPP-4 inhibition, and hormone regulation (leptin, adiponectin, insulin) to support satiety, appetite control, metabolic balance, and weight management for manufacturers of foods, beverages, and dietary supplements.

Differentiator

Problem solved

Functional benefit

Brands

• Dyglomera: Trademarked brand of patented extract of Dichrostachys glomerata supporting metabolic balance and healthy body weight.
• DygloFit
• CQR-300
• Somnoril
• IGOB131
• LeptiCore

Products and services

• CQR-300 Patented extract of Cissus quadrangularis clinically proven to support healthy weight loss, cardiovascular health, and metabolic wellness through DPP-4 inhibition to increase GLP-1 activity. Sold as an ingredient to dietary supplement and food/beverage manufacturers and as a 30-day direct-to-consumer product.
• Dyglomera Trademarked brand of patented Dichrostachys glomerata extract that restores metabolic balance and supports healthy body weight and composition through GLP-1, insulin, leptin, and adiponectin modulation, including DPP-4 inhibition to increase natural GLP-1 activity.
• DygloFit Trademarked brand of the same patented Dichrostachys glomerata extract sold as an ingredient for weight management formulations, working through complementary mechanisms including GLP-1, insulin, leptin, and adiponectin modulation.
• Somnoril Patented extract of Dichrostachys glomerata clinically proven to enhance restorative sleep, promote sustainable weight loss, and improve metabolic wellness through complementary mechanisms. Sold as an ingredient to manufacturers and as a 30-day direct-to-consumer product.
• IGOB131 Patented, FDA GRAS-affirmed natural extract of Irvingia gabonensis (African mango) clinically proven to restore metabolic balance for healthy body weight and composition through modulation of adiponectin, leptin, C-reactive protein, and cholesterol levels.
• LeptiCore Patented multifunctional ingredient complex combining plant-based polysaccharides, esterified fatty acids, pomegranate extract, beta carotene, and blue green algae that supports healthy weight management through leptin modulation and serotonin enhancement.

Quantifiable outcome

• Dyglomera increased active GLP-1 levels by +294.7% (+38.6 pg/mL) after 16 weeks vs +36.1% for placebo
• +7 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/gateway-health-alliances

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gateway Health Alliances inc